NCT05705492
- Conditions
- Advanced Biliary Tract Carcinoma, Advanced Esophageal Carcinoma, Advanced Lung Carcinoma, +30 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Metastatic Esophageal Carcinoma
Explore clinical trials studying Metastatic Esophageal Carcinoma. Study availability and eligibility vary by location and protocol.
7 public trials
3 recruiting studies
Metastatic Esophageal Carcinoma trial results
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04221893
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Anal Canal Carcinoma, +72 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- John Muir Medical Center-Walnut Creek Walnut Creek, California, United States
Not Yet Recruiting
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
NCT07594626
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +27 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT03008278
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +21 more
- Locations
-
- City of Hope Corona Corona, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
Active, Not Recruiting
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
NCT05038254
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +71 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
NCT06251973
- Conditions
- Adenocarcinoma Of Esophagus, Advanced Unresectable Gastric Adenocarcinoma, Digestive System Diseases, +22 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities) Commack, New York, United States